Thomas E. Stinchcombe
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 109
- Lung Cancer Diagnosis and Treatment 56
- Oncology 112
- Lung Cancer Research Studies 51
- Colorectal Cancer Treatments and Studies 23
- Cancer Immunotherapy and Biomarkers 21
- Cancer Treatment and Pharmacology 11
- Co-authors
- Mark A. Socinski (70 shared papers)Patrick J. Roberts (3 shared papers)Carrie B. Lee (15 shared papers)Everett E. Vokes (32 shared papers)Dominic T. Moore (18 shared papers)Vinicius Ernani (1 shared paper)Julian Rosenman (13 shared papers)Xiaofei Wang (23 shared papers)
- Journals
- Journal of Thoracic Oncology (40 papers)Journal of Clinical Oncology (34 papers)Lung Cancer (15 papers)Clinical Lung Cancer (11 papers)The Oncologist (10 papers)
- Partner nations
- United StatesHong KongCanada
In The Last Decade
Thomas E. Stinchcombe
208 papers receiving 7.1k citations
Thomas E. Stinchcombe's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 2.9k
- Pulmonary and Respiratory Medicine 2.9k
- Cancer Research 601
- Hematology 353
- Pathology and Forensic Medicine 361
Countries citing papers authored by Thomas E. Stinchcombe
This map shows the geographic impact of Thomas E. Stinchcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Stinchcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Stinchcombe more than expected).
Fields of papers citing papers by Thomas E. Stinchcombe
This network shows the impact of papers produced by Thomas E. Stinchcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Stinchcombe. The network helps show where Thomas E. Stinchcombe may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Stinchcombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies Hit paper breakdown → | 2002 | 608 |
| 2 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 477 |
| 3 | Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy Hit paper breakdown → | 2017 | 315 |
| 4 | 2007 | 277 | |
| 5 | 2010 | 204 | |
| 6 | 2012 | 192 | |
| 7 | 2013 | 192 | |
| 8 | 2018 | 185 | |
| 9 | 2007 | 180 | |
| 10 | 2019 | 159 | |
| 11 | 2011 | 155 | |
| 12 | 2013 | 151 | |
| 13 | 2012 | 131 | |
| 14 | 2009 | 122 | |
| 15 | 2016 | 119 | |
| 16 | 2019 | 117 | |
| 17 | 2007 | 103 | |
| 18 | 2017 | 95 | |
| 19 | 2016 | 94 | |
| 20 | 2019 | 89 |
About Thomas E. Stinchcombe
Thomas E. Stinchcombe is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 219 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (109 papers), Lung Cancer Diagnosis and Treatment (56 papers), Lung Cancer Research Studies (51 papers), Colorectal Cancer Treatments and Studies (23 papers), Cancer Immunotherapy and Biomarkers (21 papers), Cancer Genomics and Diagnostics (19 papers), Radiomics and Machine Learning in Medical Imaging (14 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.9k citations), Cancer Research (601 citations), Hematology (353 citations) and Pathology and Forensic Medicine (361 citations). Thomas E. Stinchcombe has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Mark A. Socinski, Patrick J. Roberts, Carrie B. Lee, Everett E. Vokes, Dominic T. Moore, Vinicius Ernani, Julian Rosenman, Xiaofei Wang, Karen Kelly and David R. Spigel. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Clinical Lung Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.